OakChart

Azenta Inc

AZTAHealthcare·Medical Instruments & Supplies·USA·Mid·NASD·Nov 11 • 3:59 PM ET

48.90+8.42 (20.80%)
2026-11-12 03:23 CET
Market cap
2,142.23 USD m
Revenue, TTM
621.70 USD m
Net income, TTM
-166.99 USD m
Free cash flow, TTM
27.43 USD m
EPS diluted, TTM
-3.62
P/E
-
Compare

Price

AZTA against its 20, 50 and 200-day averages
2050200beat
20.0030.0040.0050.001.7M3.4MVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26AZTAclose 48.9020-day 38.3250-day 35.99200-day 28.3648.9052w low

2.3% under the 52-week high of 50.06 on 11 Nov 2026. 52-week low 15.93 on 18 May 2026. Last 15 sessions, 42.8% high to low

Volume 2.60× normal · the line is the 50-bar volume average

Profile

AZTA
52-week range, 100% of the way up
15.9346.41

Azenta, Inc. is a global provider of life sciences solutions, enabling organizations worldwide to bring impactful breakthroughs and therapies to market faster. The company offers a suite of reliable cold-chain sample management solutions and multiomics services supporting drug development, clinical research, and advanced cell therapies for pharmaceutical, biotechnology, academic, and healthcare institutions globally. It operates through the following segments: Sample Management Solutions and Multiomics. The Sample Management Solutions segment provides end-to-end sample management products and services, including Sample Repository Services (SRS). Its core products include automated stores, cryogenic systems, automated sample tubes, consumables and instruments, and controlled-rate thawing devices. The Multiomics segment delivers genomic and other sample analysis services, including gene sequencing, gene synthesis, and related services. The company was founded in 1978 and is headquartered in Burlington, MA.

IndexRUT
Employees3000
IPOFeb 02, 1995
Beta1.46
ATR, 14d2.71
Rel volume2.60
Short float12.53%
Insider own1.57%
Inst own114.52%

Snapshot

6 groups

Valuation

IndexRUT
Market Cap2.14B
Enterprise Value1.86B
Income-166.99M
Sales621.70M
Book/sh33.46
Cash/sh7.60
Dividend Est.-
Dividend TTM-
Dividend Ex-DateDec 02, 2021
Dividend Gr. 3/5Y- -
Payout-
Employees3000
IPOFeb 02, 1995

Ratios

P/E-
Forward P/E59.11
PEG2.44
P/S3.45
P/B1.46
P/C6.43
P/FCF78.10
EV/EBITDA43.94
EV/Sales2.99
Quick Ratio2.34
Current Ratio2.68
Debt/Eq0.04
LT Debt/Eq0.04
Option/ShortYes / Yes

Earnings

EPS (ttm)-3.62
EPS next Y0.83
EPS next Q0.07
EPS this Y5.73%
EPS next Y63.01%
EPS next 5Y24.22%
EPS past 3/5Y-158.10% -
Sales past 3/5Y-2.22% 3.89%
EPS Y/Y TTM-196.27%
Sales Y/Y TTM4.65%
EPS Q/Q-85.82%
Sales Q/Q4.96%
EarningsNov 10 AMC
EPS/Sales Surpr.152.25% 4.33%

Ownership

Insider Own1.57%
Insider Trans1.53%
Inst Own114.52%
Inst Trans-6.09%
ROA-8.38%
ROE-10.11%
ROIC-11.52%
Gross Margin44.23%
Oper. Margin-2.27%
Profit Margin-26.86%
SMA2027.62%
SMA5035.89%
SMA20072.44%
Trades-

Technical

Shs Outstand43.81M
Shs Float43.12M
Short Float12.53%
Short Ratio5.65
Short Interest5.40M
52W High46.41 5.37%
52W Low15.93 206.97%
Volatility6.67% 6.26%
ATR (14)2.71
RSI (14)71.26
Beta1.46
Rel Volume2.60
Avg Volume957.14K
Volume2,488,915

Performance

Perf Week24.94%
Perf Month29.13%
Perf Quarter44.21%
Perf Half Y187.14%
Perf YTD47.02%
Perf Year59.49%
Perf 3Y2.88%
Perf 5Y-57.03%
Perf 10Y226.00%
Recom2.00
Target Price49.20
Prev Close40.48
Price48.90
Change %20.80%

Analyst ratings

latest 10 of 14
DateActionAnalystRating changeTargetImplied
Jan 05, 2026UpgradeEEvercore ISIIn-line → Outperform$50+2.2%
Dec 19, 2025ReiteratedNNeedhamBuy$42 → $44-10.0%
Oct 30, 2025UpgradeJJefferiesHold → Buy$38-22.3%
Aug 06, 2025UpgradeRRaymond JamesMkt Perform → Outperform$35-28.4%
Jul 22, 2025ResumedSStephensEqual-Weight$35-28.4%
Dec 18, 2024UpgradeSStephensEqual-Weight → Overweight$50 → $60+22.7%
Apr 04, 2024InitiatedJJefferiesHold$64+30.9%
Feb 01, 2024ReiteratedRB. Riley SecuritiesBuy$61 → $79+61.6%
Jul 19, 2023InitiatedRRaymond JamesMkt Perform
May 10, 2023DowngradeKKeyBanc Capital MarketsOverweight → Sector Weight

Peers

Mkt cap
TickerCompanyMkt cap
AVTRAvantor Inc10.66B
TMOThermo Fisher Scientific Inc265.92B
TWSTTwist Bioscience Corp8.07B
RGENRepligen Corp11.03B
BIOBio-Rad Laboratories Inc10.39B
TECHBio-Techne Corp11.44B
RVTYRevvity Inc17.66B
CRLCharles River Laboratories International Inc16.42B
AAgilent Technologies Inc49.89B
BRKRBruker Corp9.53B

Insider trading

2 filings
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Starr EphraimSVP, Gen Counsel & SecretaryJul 31 '26Buy24.173358,09668,728Aug 04 06:11 PM
Cornog William LDirectorMay 18 '26Buy16.3810,000163,80019,703May 19 04:10 PM

Held by

AUM
TickerCompanyAUM
IJRiShares Core S&P Small-Cap ETFAUM: 106.27B
IWMiShares Russell 2000 Index FundAUM: 77.38B
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
VBVanguard Morningstar Small-Cap ETFAUM: 79.59B
VBRVanguard Morningstar Small-Cap Value ETFAUM: 37.76B
DFSVUS Small Cap Value Portfolio ETF Class SharesAUM: 8.52B
IWNiShares Russell 2000 Value ETFAUM: 14.10B
VXFVanguard Extended Market Index ETFAUM: 30.47B
SPSMState Street SPDR Portfolio S&P 600TM Small Cap ETFAUM: 16.06B
AVUVAvantis U.S. Small Cap Value ETFAUM: 32.39B

News

latest 14 of 100
  • Azenta's 33% Adjusted EPS Jump Flatters A Flat Quarter, But The FY27 Outlook Raises The Stakes (Earnings Whispers) +20.80%
  • Azenta Reports Fourth Quarter and Full Year Results for Fiscal 2026, Ended September 30, 2026. (PR Newswire)
  • Azenta Announces Strategic Investments to Advance the Next Generation of GENEWIZ Gene Synthesis Capabilities (PR Newswire) -5.35%
  • Azenta Announces Fiscal 2026 Fourth Quarter and Full Year Conference Call and Webcast (PR Newswire)
  • Azenta Receives Full Repayment of $35 Million Vendor Loan Related to Sale of B Medical Systems (PR Newswire)
  • AZENTA ANNOUNCES LEADERSHIP TRANSITION (PR Newswire) -12.09%
  • Azenta Inc (AZTA) (Q3 2026) Earnings Call Highlights: Organic Growth Surges 9% Amid Strategic ... (GuruFocus.com) +5.61%
  • Azenta Reports Third Quarter Results for Fiscal 2026, Ended June 30, 2026. (PR Newswire)
  • SpaceXs First Earnings Offer a Chance to Reverse Stocks Plunge (Bloomberg)
  • Azenta Announces Fiscal 2026 Third Quarter Conference Call and Webcast (PR Newswire)
  • Azenta Completes Sale of B Medical Systems (PR Newswire)
  • Azenta Publishes 2025 Environmental, Social, and Governance (ESG) Report (PR Newswire) +5.22%
  • Azenta Reports Second Quarter Results for Fiscal 2026, Ended March 31, 2026, Updates Full Year Fiscal 2026 Guidance, and Extends Long-Range Plan to 2029 (PR Newswire) -25.31%
  • Azenta Announces Fiscal 2026 Second Quarter Conference Call and Webcast (PR Newswire) +6.23%

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q42026-11-100.2800.1110.157167.09160.166
2026Q32026-08-040.1600.1140.054161.18149.316
2026Q22026-05-05-0.0400.123-3.491144.8148.476
2026Q12026-02-040.0900.138-0.336148.64147.098
2025Q42025-11-210.2100.1901.106159.19156.28
2025Q32025-08-050.1900.136-1.154143.94149.388
2025Q22025-05-070.0500.070-0.885143.42140.887
2025Q12025-02-050.0800.057-0.292147.51146.217
2024Q42024-11-120.1800.103-0.104170.06169.667
2024Q32024-08-060.1600.081-0.124172.81167.267
2024Q22024-05-080.0500.024-2.469159.13159.366
2024Q12024-02-070.020-0.034-0.277154.32150.965
2023Q42023-11-130.1300.0180.057172163.936
2023Q32023-08-080.130-0.026-0.039166153.915
2023Q22023-05-09-0.060-0.022-0.071148161.95
2023Q12023-02-080.1200.099-0.155178.37181.385

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2019FY0.7700.7640.398782777
2020FY1.2601.1510.878897.27885.15
2021FY1.9002.5321.487988.11,188
2022FY0.5100.424-5.727555551.68
2023FY0.3100.203-0.215665656.85
2024FY0.4100.334-3.101656.32655.38
2025FY0.5100.503-1.219593.82591.02
2026FY0.4800.318-3.700621.7614.79
2027FY-0.508--648.82
2028FY-0.827--683.9
2029FY-0.920---
2030FY-1.760--742.8

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2027Q1S2026-11-11530157.25154.3159.4
2027Q1S2026-11-10400154.3152.2156.84
2027Q1S2026-10-12400154.3152.2156.84
2027Q1S2026-08-05300154.99153.87156.8
2027Q1S2026-07-21300155.21154.3156.8
2027Q1S2026-07-20301155.21154.3156.8
2027Q1S2026-05-07303155.21154.3156.8
2027Q1S2026-05-06312158.35154.54163.7
2027Q1S2026-04-21320162.87161163.92
2027Q1S2026-04-17320161.31159163.92
2027Q1S2026-03-31430160.64158.63163.92
2027Q1S2026-03-16330160.52158.63163.92
2027Q1S2026-03-03320158.83158.63159
2027Q1S2026-02-06330158.83158.63159

Estimate history

EPS, annual1.6430.3980.8781.487-5.727-0.215-3.101-1.219-3.7
Period201820192020202120222023202420252026
EPS, quarterly-0.104-0.292-0.885-1.1541.106-0.336-3.4910.0540.157
PeriodQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26
Sales, annual631.56780.848388.537513.703555.498665.072573.448593.821621.703
Period201820192020202120222023202420252026
Sales, quarterly170.062147.51143.418143.942159.192148.642144.795161.178167.088
PeriodQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26
Shares, annual70.70272.29873.83274.34775.0257.83245.5745.85941.757
Period201820192020202120222023202420252026
Shares, quarterly45.5745.69245.77645.78545.85946.01846.09143.76541.757
PeriodQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26

Income statement, annual

Currency USD, millions
MetricTTM2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY
Total Revenue621.70621.70593.82573.45665.07555.50513.70388.54780.85
Cost of Goods Sold Incl. D&A346.74346.74323.54318.83431.82324.88299.19243.66488.82
Gross Profit274.96274.96270.28254.62233.26230.62214.51144.87292.02
Selling, General and Administrative Excl. Other289.09295.44281.55284.60315.45254.64210.91172.40236.89
Research and Development37.9237.9230.3931.5233.9627.5422.4116.1256.37
Other Operating Expense--0.000.000.000.000.000.000.00
Operating Income-14.13-20.48-11.27-29.98-82.20-24.023.60-27.5355.13
Interest Expense--0.000.00-4.592.042.9422.25
Unusual Expense160.57154.2215.5821.30-9.071.3434.699.0723.43
Net Income Before Taxes-151.01-151.01-7.14-19.12-30.43-9.94-48.97-40.299.44
Income Taxes6.866.86-31.605.24-17.551.35-20.10-13.93-0.11
Consolidated Net Income-157.87-157.8724.46-24.37-12.88-11.29-28.87-26.369.55
Net Income From Continuing Operations-157.87-157.8724.46-24.37-12.88-11.29-28.87-26.369.55
Net Income-166.99-166.99-55.76-164.90-14.26-428.96110.7564.8528.82
EPS (Recurring)-1.26-1.31-0.98-2.82-0.31-5.711.810.960.62
EPS (Basic, Before Extraordinaries)-3.62-3.70-1.22-3.10-0.22-5.731.490.880.40
EPS (Diluted)-3.62-3.70-1.22-3.10-0.22-5.731.490.880.40
EBITDA42.3635.9449.9460.763.3929.6860.4737.97109.58
Non-Operating Income (Expense)23.6923.6919.7032.1642.6920.02-15.84-0.75-0.01
Other After Tax Adjustments--0.000.000.000.000.000.000.00
Stock Option Compensation Expense10.5710.0516.4811.827.418.4320.0411.9114.22
Price To Earnings Ratio------68.7952.6991.84
Price To Sales Ratio2.432.532.214.495.005.7814.838.793.43
Gross Margin44.2344.2345.5244.4035.0741.5241.7637.2937.40
Operating Margin-2.27-3.29-1.90-5.23-12.36-4.320.70-7.087.06
Net Margin-26.86-26.86-9.39-28.76-2.14-77.2221.5616.693.69
Shares Outstanding41.7641.7645.8645.5757.8375.0274.3573.8372.30
Market Capitalization2,142.232,142.231,316.522,369.473,019.123,215.377,604.273,412.152,674.45

Income statement, quarterly

Currency USD, millions
Metric2026Q42026Q32026Q22026Q12025Q42025Q32025Q22025Q1
Total Revenue167.09161.18144.79148.64159.19143.94143.42147.51
Cost of Goods Sold Incl. D&A90.2288.8282.7684.9486.9276.1877.5383.41
Gross Profit76.8772.3662.0363.7172.2767.7665.8964.10
Selling, General and Administrative Excl. Other72.3073.5074.7068.5869.3366.1873.2771.97
Research and Development10.448.859.439.198.266.686.876.38
Other Operating Expense-0.000.000.000.000.000.000.00
Operating Income4.56-1.15-12.67-4.882.941.58-7.39-7.88
Interest Expense-0.000.000.000.000.00--
Unusual Expense2.063.03153.122.361.042.308.763.48
Net Income Before Taxes7.550.85-157.34-2.066.303.44-10.51-5.85
Income Taxes1.682.38-0.323.13-45.352.767.683.57
Consolidated Net Income5.87-1.53-157.02-5.1951.650.68-18.18-9.42
Net Income From Continuing Operations5.87-1.53-157.02-5.1951.650.68-18.18-9.42
Net Income6.792.46-160.80-15.4350.88-52.81-40.46-13.34
EPS (Recurring)0.190.10-1.16-0.301.12-1.12-0.75-0.24
EPS (Basic, Before Extraordinaries)0.160.05-3.49-0.341.11-1.15-0.88-0.29
EPS (Diluted)0.160.05-3.49-0.341.11-1.15-0.88-0.29
EBITDA19.8212.441.338.7717.3816.306.576.38
Non-Operating Income (Expense)5.055.028.455.184.404.155.655.50
Other After Tax Adjustments-0.000.000.000.000.000.000.00
Stock Option Compensation Expense-1.953.714.953.861.362.216.344.04
Price To Sales Ratio2.431.881.632.572.222.332.503.51
Gross Margin46.0044.8942.8442.8645.4047.0745.9443.45
Operating Margin2.73-0.71-8.75-3.281.851.10-5.15-5.34
Net Margin4.061.52-111.05-10.3831.96-36.69-28.21-9.04
Shares Outstanding41.7643.7646.0946.0245.8645.7845.7845.69
Market Capitalization2,142.231,176.29973.281,529.601,316.521,409.111,582.902,284.59

Balance sheet, annual

Currency USD, millions
Metric2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Cash & Short Term Investments332.95343.28433.261,022.431,952.63234.65254.27339.30243.99
Short Term Receivables187.11189.21206.94180.74181.96135.18109.59179.60125.19
Inventories77.1274.9671.32128.2085.5460.4037.1299.4496.99
Other Current Assets26.36100.89121.5187.59239.21347.14248.4728.8097.89
Total Current Assets623.54708.34833.031,418.962,459.35777.37649.45647.14564.06
Net Property, Plant & Equipment234.26208.00216.03272.32208.53180.37112.06100.6759.99
Total Investments and Advances169.20202.9257.45111.82352.459.366.412.857.24
Long-Term Note Receivable45.60--------
Intangible Assets626.26804.21816.451,078.64692.02655.89665.50739.77355.83
Deferred Tax Assets0.500.730.840.571.1710.043.985.0643.80
Other Assets9.03135.38176.473.412.61186.49121.8720.5164.35
Total Assets1,708.382,059.582,100.262,885.723,716.121,819.511,559.271,516.001,095.26
Short Term Debt Incl. Current Port. of LT Debt-7.788.6710.187.025.615.930.832.00
Accounts Payable55.2237.7233.3435.8038.6542.3625.6958.9255.87
Income Tax Payable3.529.429.097.3828.428.711.9899.266.75
Other Current Liabilities174.35182.75154.99157.58156.45288.40177.52113.26100.00
Total Current Liabilities233.09237.67206.09210.93230.55345.09211.12272.27164.62
Long Term Debt51.8752.1557.6561.8049.3394.7868.8452.98194.07
Provision for Risks Charges0.000.000.000.381.952.6819.3723.615.36
Deferred Tax Liabilities15.3418.2518.1867.3064.5613.0317.8020.647.13
Other Liabilities10.8622.6349.0910.816.3738.6128.537.556.25
Total Liabilities311.16330.70331.02351.22352.74494.18345.65377.05377.43
Non-Equity Reserves-1.901.400.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity1,397.221,726.991,767.852,534.503,363.391,325.331,213.611,138.95717.83
Total Shareholders Equity1,397.221,726.991,767.852,534.503,363.391,325.331,213.611,138.95717.83
Accumulated Minority Interest-0.000.000.000.000.000.000.000.00
Total Equity1,397.221,726.991,767.852,534.503,363.391,325.331,213.611,138.95717.83
Total Liabilities & Stockholders Equity1,708.382,059.582,100.262,885.723,716.121,819.511,559.271,516.001,095.26
Book Value Per Share33.4637.6638.7943.8244.8317.8316.4415.7510.15
Tangible Book Value Per Share18.4620.1220.8825.1735.619.007.425.525.12
Full-Time Employees-3,0003,0003,5003,1002,8003,1592,9841,548
Price to Book Ratio1.460.791.231.130.965.742.812.353.47
Return on Assets-8.381.18-0.98-0.39-0.41-1.71-1.710.737.29
Return on Equity-10.111.40-1.13-0.44-0.48-2.27-2.241.0310.23
Return on Invested Capital-11.52-3.13-9.03-0.55-12.577.805.062.4212.78
Quick Ratio2.342.663.706.1210.302.082.902.012.84
Current Ratio2.682.984.046.7310.672.253.082.383.43

Cash flow, annual

Currency USD, millions
MetricTTM2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY
Net Income-166.99-166.99-55.76-164.90-14.262,132.86110.7564.85437.42
Depreciation56.5256.5261.2190.7485.5853.7065.3365.5054.45
Other Funds (Non Cash)169.08169.08116.61136.74-7.34-2,604.9442.25-74.41-392.08
Funds from Operations53.4553.4595.0246.7035.34-393.91201.0750.5484.62
Extraordinary Item--0.000.000.000.000.000.000.00
Changes in Working Capital4.064.06-22.843.04-17.85-72.13-51.21-12.676.27
Cash from Operating Activities57.5157.5172.1849.7417.49-466.05149.8637.8790.90
Capital Expenditures-30.08-30.08-33.86-37.39-39.44-77.44-52.80-39.92-23.86
Net Assets From Acquisitions-11.15-11.150.000.00-386.51-125.88-95.51-15.74-442.70
Sale of Fixed Assets and Businesses54.5054.500.000.000.002,939.120.000.00661.64
Purchase or Sale of Investments-47.08-47.08-59.83260.65828.01-1,270.21-0.0333.9316.23
Purchase of Investments-375.68-375.68-451.41-405.57-236.19-1,975.60-0.15-10.89-35.23
Sale Or Maturity of Investments328.61328.61391.58666.231,064.21705.380.1244.8251.46
Other Uses--0.000.000.000.000.00-1.000.00
Other Sources0.000.003.221.4829.310.002.000.000.00
Cash from Investing Activities-33.80-33.80-90.46224.74431.381,465.59-146.35-22.74211.31
Cash Dividends Paid--0.000.000.00-7.49-29.73-29.51-28.89
Change in Capital Stock-116.08-116.082.77-658.42-838.515.255.814.593.42
Repurchase of Common Pref Stock-118.29-118.290.00-661.70-838.510.000.000.000.00
Sale of Common Pref Stock2.202.202.773.280.005.255.814.593.42
Proceedsfrom Stock Options2.202.202.773.280.005.255.814.593.42
Issuance or Reduction of Debt, Net-0.75-0.75-0.98-0.78-0.58-50.11-1.99-2.10-165.69
Change in Long Term Debt-0.75-0.75-0.98-0.78-0.58-50.11-1.99-2.10-165.69
Issuance of Long Term Debt--0.000.000.000.000.000.00685.70
Reduction of Long Term Debt-0.75-0.75-0.98-0.78-0.58-50.11-1.99-2.10-851.39
Net Financing Active Other Cash Flow-2.67-2.67-11.380.00-4.99-10.400.000.000.00
Other Financing Activities Uses-2.67-2.67-11.380.00-4.99-10.400.000.000.00
Cash from Financing Activities-119.50-119.50-9.59-659.21-844.08-62.76-25.91-27.02-191.16
Exchange Rate Effect-2.58-2.583.5721.6737.95-180.825.219.25-3.59
Net Change in Cash-98.37-98.37-24.30-363.06-357.25755.96-17.19-2.65107.46
Free Cash Flow27.4327.4338.3212.35-21.95-539.4897.05-2.0667.04
Preferred Dividends (Cash Flow)--0.000.000.000.000.000.000.00
Price to Free Cash Flow55.0457.4134.28208.55--113.19-70.28
Deferred Taxes & Investment Tax Credit--5.17-27.04-15.89-28.6524.47-17.27-5.41-15.16

Balance sheet, quarterly

Currency USD, millions
Metric2026Q42026Q32026Q22026Q12025Q42025Q3
Cash & Short Term Investments332.95328.21382.93412.05343.28321.17
Short Term Receivables187.11178.52165.66186.06189.21164.63
Inventories77.1279.0878.5182.4674.9680.51
Other Current Assets26.3695.5499.8999.34100.89112.17
Total Current Assets623.54681.35726.99779.90708.34678.48
Net Property, Plant & Equipment234.26233.85231.28209.78208.00214.30
Total Investments and Advances169.20200.33181.91158.88202.92228.63
Intangible Assets626.26633.14644.50799.16804.21811.75
Deferred Tax Assets0.500.490.500.530.730.78
Other Assets9.03127.05118.70126.18135.3885.19
Total Assets1,708.381,876.211,903.892,074.432,059.582,019.13
Short Term Debt Incl. Current Port. of LT Debt-0.000.000.007.780.00
Accounts Payable55.2239.3833.1438.7737.7237.98
Income Tax Payable3.526.788.7511.869.428.85
Other Current Liabilities174.35226.42215.30216.58182.75198.60
Total Current Liabilities233.09272.57257.19267.21237.67245.44
Long Term Debt51.8753.9755.7154.4652.1552.63
Provision for Risks Charges0.000.000.000.000.000.42
Deferred Tax Liabilities15.3415.8415.7515.2518.2520.58
Other Liabilities10.8623.7020.5622.6822.6326.43
Total Liabilities311.16366.08349.21359.60330.70345.50
Non-Equity Reserves-0.000.000.001.900.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity1,397.221,510.131,554.681,714.831,726.991,673.63
Total Shareholders Equity1,397.221,510.131,554.681,714.831,726.991,673.63
Accumulated Minority Interest-0.000.000.000.000.00
Total Equity1,397.221,510.131,554.681,714.831,726.991,673.63
Total Liabilities & Stockholders Equity1,708.381,876.211,903.892,074.432,059.582,019.13
Book Value Per Share33.4634.5133.7337.2637.6636.55
Tangible Book Value Per Share18.4620.0419.7519.9020.1218.82
Full-Time Employees-2,9002,900-3,0003,000
Price to Book Ratio1.460.760.570.880.790.83
Return on Assets-8.38-5.75-5.571.411.19-1.47
Return on Equity-10.11-7.04-6.751.691.41-1.74
Return on Invested Capital0.470.16-9.99-0.872.86-3.06
Quick Ratio2.342.212.522.612.662.44
Current Ratio2.682.502.832.922.982.76

Cash flow, quarterly

Currency USD, millions
Metric2026Q42026Q32026Q22026Q12025Q42025Q3
Net Income6.792.46-160.80-15.4350.84-52.81
Depreciation15.2913.5814.0013.6518.2814.72
Other Funds (Non Cash)-1.09-2.65159.8013.030.5571.24
Funds from Operations19.3815.1213.495.4662.6515.02
Extraordinary Item-0.000.000.000.000.00
Changes in Working Capital2.32-13.670.0215.39-60.4810.79
Cash from Operating Activities21.701.4513.5120.852.1725.81
Capital Expenditures-9.85-6.64-7.40-6.19-7.86-10.84
Net Assets From Acquisitions0.00-0.13-11.020.000.000.00
Sale of Fixed Assets and Businesses54.500.000.000.000.000.00
Purchase or Sale of Investments22.79-7.50-96.3333.968.51-18.86
Purchase of Investments-10.33-36.52-220.14-108.69-138.42-76.75
Sale Or Maturity of Investments33.1229.02123.81142.66146.9357.89
Other Uses-0.000.000.000.000.00
Other Sources-28.0019.000.009.000.180.00
Cash from Investing Activities39.454.72-114.7536.770.83-29.70
Cash Dividends Paid-0.000.000.000.000.00
Preferred Dividends (Cash Flow)-0.000.000.000.000.00
Change in Capital Stock-67.21-50.051.180.001.220.00
Repurchase of Common Pref Stock-68.24-50.050.000.000.000.00
Sale of Common Pref Stock1.03-0.001.180.001.220.00
Proceedsfrom Stock Options1.03-0.001.180.001.220.00
Issuance or Reduction of Debt, Net-0.17-0.17-0.20-0.21-0.40-0.13
Change in Long Term Debt-0.17-0.17-0.20-0.21-0.40-0.13
Issuance of Long Term Debt-0.000.000.000.000.00
Reduction of Long Term Debt-0.17-0.17-0.20-0.21-0.40-0.13
Net Financing Active Other Cash Flow-0.15-0.10-0.00-2.420.000.00
Other Financing Activities Uses-0.15-0.10-0.00-2.420.000.00
Cash from Financing Activities-67.53-50.320.98-2.630.82-0.13
Exchange Rate Effect0.02-0.47-2.440.31-0.948.97
Net Change in Cash-6.36-44.62-102.7055.302.874.95
Free Cash Flow11.86-5.196.1114.65-5.6914.97
Price to Free Cash Flow55.04116.9632.3949.3934.4730.85

Revenue breakdown

Total Special Industry Machinery, NEC revenue2025: 593.82M
Asia Pacific2025: 23.28M
China2025: 58.35M
Europe2025: 107.37M
Other2025: 4.43M
United Kingdom2025: 35.39M
United States2025: 365.00M
Multiomics2025: 269.23M
Sample Management Solutions2025: 324.59M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-3012.53%5.4M43.1M953.25K
2026-10-1512.44%5.4M43.1M903.10K
2026-09-3012.34%5.3M43.1M742.70K
2026-09-1512.48%5.4M43.1M717.59K
2026-08-3112.40%5.4M43.3M740.24K
2026-08-1412.12%5.3M43.3M855.62K
2026-07-3112.32%5.3M43.4M1.03M
2026-07-1513.23%6.0M45.6M1.08M
2026-06-3013.64%6.2M45.6M1.12M
2026-06-1513.79%6.3M45.6M1.18M
2026-05-2912.86%5.9M45.6M1.18M
2026-05-1513.69%6.2M45.6M1.05M
2026-04-3013.07%6.0M45.6M946.68K
2026-04-1512.11%5.5M45.6M925.66K
2026-03-3111.64%5.3M45.6M858.40K
2026-03-1310.55%4.8M45.6M781.25K
2026-02-2710.24%4.7M45.6M752.07K
2026-02-1311.13%5.1M45.6M782.93K
2026-01-309.18%4.2M45.6M661.79K
2026-01-158.92%4.1M45.5M622.67K

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call17.5029.2033.400.006.2710.000.000.994-0.0230.001
call20.0026.7030.9026.905.5550.002.000.993-0.0230.001
call22.5024.2028.400.004.9360.000.000.958-0.1340.007
call25.0021.7025.9021.804.3890.002.000.952-0.1320.008
call30.0016.7021.0017.933.6429.002.000.938-0.1250.009
call35.0011.7016.0013.032.75412312.000.918-0.1160.012
call40.006.8011.009.002.01524812.000.884-0.1030.015
call45.002.356.404.301.45970.0013.000.770-0.1080.023
call50.000.202.601.801.0111.002600.488-0.1990.030
call55.000.000.600.400.7980.001,3820.190-0.0940.021
call60.000.002.350.001.1410.000.000.145-0.1130.017
call65.000.002.150.001.4300.000.000.122-0.1250.015
put17.500.003.400.002.8990.000.00-0.006-0.0210.001
put20.000.000.050.003.5020.000.00-0.028-0.0960.005
put22.500.002.200.003.4190.000.00-0.042-0.1320.007
put25.000.002.200.453.0170.000.00-0.048-0.1290.008
put30.000.001.550.012.3199.006.00-0.062-0.1220.009
put35.000.002.151.051.7188.000.00-0.082-0.1120.012
put40.000.000.550.251.17620.0020.00-0.116-0.0980.015
put45.000.000.700.500.7255.0014.00-0.214-0.0910.022
put50.000.604.702.651.3570.0021.00-0.512-0.1940.030
put55.005.107.600.001.1960.000.00-0.810-0.0880.021
put60.009.2013.4013.201.9160.005.00-0.855-0.1060.017
put65.0014.2018.400.002.2730.000.00-0.878-0.1180.015

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-108-KCurrent report2026-11-10SEC
2026-10-308-KCurrent report2026-10-28SEC
2026-10-234Statement of changes in beneficial ownership of securities2026-10-22SEC
2026-10-078-KCurrent report2026-10-05SEC
2026-09-234Statement of changes in beneficial ownership of securities2026-09-22SEC
2026-09-178-KCurrent report2026-09-11SEC
2026-09-164Statement of changes in beneficial ownership of securities2026-09-14SEC
2026-09-164Statement of changes in beneficial ownership of securities2026-09-14SEC
2026-09-164Statement of changes in beneficial ownership of securities2026-09-14SEC
2026-09-164Statement of changes in beneficial ownership of securities2026-09-14SEC
2026-09-164Statement of changes in beneficial ownership of securities2026-09-14SEC
2026-09-164Statement of changes in beneficial ownership of securities2026-09-15SEC
2026-09-093Initial statement of beneficial ownership of securities2026-08-31SEC
2026-09-048-KCurrent report2026-09-03SEC
2026-08-248-KCurrent report2026-08-22SEC
2026-08-114Statement of changes in beneficial ownership of securities2026-08-09SEC
2026-08-118-KCurrent report2026-08-10SEC
2026-08-0610-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-044Statement of changes in beneficial ownership of securities2026-07-31SEC
2026-08-048-KCurrent report2026-08-04SEC
2026-07-088-KCurrent report2026-07-01SEC
2026-05-26SDSpecialized Disclosure ReportSEC
2026-05-194Statement of changes in beneficial ownership of securities2026-05-18SEC
2026-05-184Statement of changes in beneficial ownership of securities2026-05-15SEC
2026-05-124Statement of changes in beneficial ownership of securities2026-02-05SEC
2026-05-0810-QQuarterly report pursuant to Section 13 or 15(d)2026-03-31SEC
2026-05-08S-8Initial registration statement for securities to be offered to employees pursuant to employee benefit plansSEC
2026-05-058-KCurrent report2026-05-05SEC
2026-04-304Statement of changes in beneficial ownership of securities2026-04-28SEC
2026-04-28SCHEDULE 13GSEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080000
2026-078.10K100
2026-060000
2026-05163.80K100
2026-040000
2026-030000
2026-020000
2026-010000
2025-120000
2025-110000

Institutional holders

Manager% owned
-

Funds

Fund% owned
iShares Core S&P Small-Cap ETF5.36%
VANGUARD TOTAL STOCK MARKET INDEX FUND2.87%
iShares Russell 2000 ETF2.38%
VANGUARD SMALL-CAP INDEX FUND2.06%
VANGUARD SMALL-CAP VALUE INDEX FUND1.31%
VANGUARD EXPLORER FUND1.14%
Congress Small Cap Growth Fund1.13%
Allspring Special Small Cap Value Fund1.13%
Columbia Small Cap Value Discovery Fund1.05%
VANGUARD EXTENDED MARKET INDEX FUND1.02%

OakChart. AZTA. Cached 15 minutes.